|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.05 EUR | +0.13% |
|
-.--% | - |
| 06-10 | Dsm-Firmenich Receives FDA Approval for PARSOL Shield, New Sun Protection Ingredient for the U.S | CI |
| 06-10 | DSM-Firmenich's Sunscreen Ingredient Gets US FDA's Nod | MT |
Upcoming events on DSM-Firmenich
| 2026-07-30 | Earnings release - Q2 2026 | |
| 2026-11-03 | Sales and Revenue Release - Q3 2026 |
Past events on DSM-Firmenich
| 2026-05-07 | Annual General Meeting | 04:30 |
| 2026-05-05 | Sales and Revenue Release - Q1 2026 | |
| 2026-03-12 | Présentation aux Actionnaires / Analystes | 05:30 |
| 2026-02-12 | Earnings presentation | 03:00 |
| 2026-02-11 | Earnings release - Annual 2025 | |
| 2026-02-09 | Présentation aux Actionnaires / Analystes | 03:00 |
| 2025-10-29 | Sales and Revenue Release - Q3 2025 | |
| 2025-07-31 | Earnings presentation | 03:00 |
| 2025-07-30 | Earnings release - Q2 2025 |
Past dividends on DSM-Firmenich
| 2026-05-11 | Ex-dividend date - 0.86 CHF | 00:00 |
| 2026-05-11 | Ex-dividend date for special dividend - 1.64 CHF | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 12 310 11 631 5.84% | 12 799 12 807 -0.06% | 12 521 12 594 -0.58% | 9 183 | 9 606 | 10 054 |
|
EBITDA Million EUR | Released Forecast Spread | 1 777 1 777 0.01% | 2 118 2 081 1.76% | 2 279 2 296 -0.75% | 1 775 | 1 926 | 2 066 |
|
EBIT Million EUR | Released Forecast Spread | 850 728 16.75% | 1 213 1 065 13.88% | 1 114 1 392 -19.95% | 1 261 | 1 401 | 1 553 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -647 -512 -26.34% | 427 641 -33.43% | 977 1 013 -3.54% | 672 | 826 | 992 |
|
Net income Million EUR | Released Forecast Spread | 2 131 -113 1992.29% | 250 460 -45.66% | 694 624 11.25% | 500 | 626 | 753 |
|
EPS EUR | Released Forecast Spread | 9,14 -0,64 1527.83% | 0,94 1,70 -44.62% | 2,68 2,21 21.17% | 2,09 | 2,68 | 3,17 |
| Announcement Date | 15/02/24 | 13/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2026 S2 | 2027 S1 | 2027 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3 227 3 127 3.2% | 6 298 6 251 0.76% | 3 244 3 241 0.1% | 3 257 3 330 -2.19% | 6 501 6 744 -3.61% | 3 274 3 367 -2.77% | 3 236 3 254 -0.54% | 6 510 6 494 0.25% | 3 070 3 106 -1.16% | 2 941 2 984 -1.45% | 6 011 6 008 0.05% | 2 276 2 255 0.93% | 2 326 | 4 693 | 2 306 | 2 215 | 4 572 | 4 859 | 4 737 |
|
EBITDA Million EUR | Released Forecast Spread | 513 500 2.6% | 541 538 0.52% | 601 590 1.86% | 1 142 | 650 649 0.2% | 610 607 0.45% | 540 541 -0.12% | 479 486 -1.44% | 1 019 1 024 -0.46% | 434 438 -0.91% | 447 | 905 | 456 | 423 | 841 | 903 | 905 | ||
|
EBIT Million EUR | Released Forecast Spread | 525 509 3.06% | 688 782 -12.05% | 823 844 -2.53% | 291 621 -53.17% | 432 | 380 | 414 | 428 | |||||||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 265 -1 586 116.71% | ||||||||||||||||||
|
Net income Million EUR | Released Forecast Spread | 184 -1 699 110.83% | ||||||||||||||||||
|
EPS EUR | Released Forecast Spread | 0,33 | 0,57 | 0,72 | 0,89 | 0,81 | 0,68 | 0,74 | 0,50 | 0,58 | 1,68 | 0,61 | 0,66 | 1,54 | 1,66 | 1,71 | ||||
| Announcement Date | 30/07/24 | 30/07/24 | 31/10/24 | 13/02/25 | 13/02/25 | 30/04/25 | 31/07/25 | 31/07/25 | 30/10/25 | 12/02/26 | 12/02/26 | 06/05/26 | - | - | - | - | - | - | - |
| 2026-06-11 | Annual General Meeting | ||
| 2026-06-11 | Présentation aux Actionnaires / Analystes | ||
| 2026-06-14 | Earnings release - Q1 2026 | ||
| 2026-06-15 | Analyst/Investor Day | ||
| 2026-06-17 | Annual General Meeting | ||
| 2026-06-17 | Extraordinary General Meeting | ||
| 2026-06-17 | Annual General Meeting | 21:00 | |
| 2026-06-17 | Présentation aux Actionnaires / Analystes | 21:00 | |
| 2026-06-17 | Ex-dividend date - 1.4 ZAR | 00:00 | |
| 2026-06-18 | Présentation aux Actionnaires / Analystes | 09:00 |
Past sector events for DSM-Firmenich
| Today | Analyst/Investor Day | 13:00 | |
| Today | Ex-dividend date - 0.1 MYR | 00:00 | |
| 2026-06-10 | Analyst/Investor Day | 02:00 | |
| 2026-06-10 | Information meeting | 03:45 | |
| 2026-06-10 | Présentation aux Actionnaires / Analystes | 01:30 | |
| 2026-06-09 | Présentation aux Actionnaires / Analystes | 02:00 | |
| 2026-06-09 | Annual General Meeting | 02:00 | |
| 2026-06-09 | Ex-dividend date - 20.11 HUF | 00:00 | |
| 2026-06-08 | Board of Directors Meeting | ||
| 2026-06-08 | Ex-dividend date - 7.99302 CLP | 00:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- DSFIR Stock
- DSM Stock
- Calendar DSM-Firmenich
Select your edition
All financial news and data tailored to specific country editions
















